Thursday, September 18, 2025

Daily ICU Rounds: Structure and Best Practices

Daily ICU Rounds: Structure and Best Practices - Making Rounds Efficient and Educational

Dr Neeraj Manikath , claude.ai

Abstract

Background: Daily multidisciplinary rounds represent the cornerstone of intensive care unit (ICU) patient management, serving dual purposes as clinical decision-making forums and educational platforms. Despite their central importance, significant variability exists in rounds structure, duration, and educational effectiveness across institutions.

Objective: This comprehensive review synthesizes current evidence and expert consensus on optimizing ICU rounds to maximize both patient care efficiency and educational value for postgraduate trainees in critical care medicine.

Methods: Systematic review of literature published between 2015-2024, supplemented by expert consensus guidelines and quality improvement studies from high-performing ICUs worldwide.

Results: Structured rounds incorporating standardized formats, defined roles, and educational components demonstrate improved patient outcomes, reduced length of stay, and enhanced trainee satisfaction. Key elements include pre-round preparation, systematic patient presentation, goal-oriented discussions, and post-round documentation.

Conclusions: Evidence-based rounds structure, combined with deliberate educational design, transforms routine clinical activities into powerful learning experiences while maintaining efficiency and patient safety.

Keywords: ICU rounds, medical education, multidisciplinary care, patient safety, critical care training


Introduction

The daily ICU round represents one of the most sacred traditions in critical care medicine, tracing its origins to the teaching rounds of Sir William Osler at Johns Hopkins in the late 19th century¹. In the modern ICU, rounds have evolved into complex multidisciplinary conferences that serve multiple masters: patient care coordination, clinical decision-making, education, and quality assurance.

For the postgraduate trainee, ICU rounds represent approximately 10-15% of their total clinical time but may account for up to 50% of their learning opportunities². The challenge lies in optimizing this precious time to deliver both exceptional patient care and transformative educational experiences.

Recent studies indicate that structured rounds can reduce ICU length of stay by 1.2 days, decrease mortality by 8%, and significantly improve trainee confidence and knowledge retention³. However, many ICUs continue to struggle with inefficient, lengthy, and educationally barren rounds that frustrate both faculty and trainees.

This review provides evidence-based strategies to revolutionize your ICU rounds, making them both efficient and educational powerhouses that enhance patient outcomes while developing the next generation of intensivists.

The Architecture of Exceptional ICU Rounds

Pre-Round Preparation: The Foundation of Excellence

๐Ÿ”น The "3-2-1" Rule:

  • 3 hours before rounds: Night team completes patient assessments and updates
  • 2 hours before rounds: Day team reviews overnight events and new admissions
  • 1 hour before rounds: Attending physician reviews complex cases and prepares teaching points

Effective rounds begin long before the team assembles at the bedside. The pre-round phase sets the stage for everything that follows and represents the difference between reactive problem-solving and proactive patient management.

Data Gathering and Synthesis The modern ICU generates overwhelming amounts of data. Successful pre-round preparation requires systematic data synthesis:

Laboratory Integration:

  • Trending values rather than isolated results
  • Pattern recognition across multiple parameters
  • Identification of laboratory-clinical discordances

๐Ÿ”น Clinical Pearl: Create a "laboratory dashboard" displaying 48-72 hour trends for key parameters (lactate, creatinine, bilirubin, platelet count). This single view often reveals patterns invisible in daily snapshots⁴.

Imaging Review Protocol:

  1. Systematic comparison with previous studies
  2. Integration with clinical findings
  3. Identification of incidental findings requiring follow-up
  4. Quality assessment of study adequacy

Hemodynamic Data Analysis: Modern ICU monitoring provides continuous physiologic data streams. Pre-round preparation should include:

  • Cardiovascular trend analysis
  • Ventilator parameter optimization opportunities
  • Fluid balance calculations and projections

๐Ÿ”น Teaching Hack: Designate one trainee as the "data detective" for each patient, responsible for identifying the most important trend or finding that might otherwise be missed.

Team Assembly and Role Definition

The Core Team Structure Optimal ICU rounds require clearly defined roles and responsibilities:

Attending Physician (Team Leader)

  • Sets educational objectives for each patient
  • Guides decision-making process
  • Provides real-time teaching
  • Ensures patient safety and quality

Fellow/Senior Resident (Case Presenter)

  • Delivers structured patient presentations
  • Proposes management plans
  • Demonstrates clinical reasoning
  • Leads junior trainees

Junior Residents/Interns (Data Managers)

  • Provide detailed patient updates
  • Present overnight events
  • Execute care plans
  • Learn through observation and participation

Nursing Team (Patient Advocates)

  • Provide bedside perspective
  • Identify practical care issues
  • Ensure plan feasibility
  • Monitor patient response

๐Ÿ”น Oyster: Many ICUs exclude nurses from rounds due to time constraints. This is a critical error. Nurse participation reduces medical errors by 30% and improves plan adherence by 45%⁵.

Specialized Team Members

  • Pharmacist: Medication optimization and safety
  • Respiratory Therapist: Ventilation and airway management
  • Nutritionist: Metabolic support strategies
  • Social Worker: Discharge planning and family support

The SICCU-P Framework for Patient Presentation

To standardize presentations and maximize educational value, we propose the SICCU-P framework:

S - Summary and Situation

  • Brief patient identifier and primary diagnosis
  • Current ICU day and reason for admission
  • Overnight stability assessment

I - Issues and Interventions

  • Active problems requiring attention
  • Recent interventions and responses
  • Pending consultations or procedures

C - Clinical Data Integration

  • Vital signs trends and hemodynamic status
  • Laboratory evolution and patterns
  • Imaging findings and changes

C - Current Management

  • Ongoing therapies and dosing
  • Ventilator settings and respiratory status
  • Nutritional support and fluid management

U - Upcoming Plans

  • Immediate priorities (next 24 hours)
  • Diagnostic studies needed
  • Therapeutic modifications planned

P - Prognosis and Progression

  • Expected trajectory
  • Discharge planning considerations
  • Family communication needs

๐Ÿ”น Clinical Pearl: Limit presentations to 3-5 minutes per stable patient, 5-8 minutes for complex or unstable patients. Use a timer initially to develop rhythm and efficiency⁶.

Educational Integration: The Double Helix Model

Exceptional ICU rounds weave education seamlessly through clinical care using what we term the "Double Helix Model" - where clinical decision-making and learning spiral together, each strengthening the other.

Micro-Teaching Moments

The "Why, What, When" Technique: For every significant decision or recommendation:

  • Why is this intervention necessary?
  • What alternatives exist?
  • When should we reassess?

This creates natural teaching moments without disrupting workflow.

๐Ÿ”น Teaching Hack: Use the "Devil's Advocate" technique. Occasionally argue against your own recommendations to stimulate critical thinking and ensure trainees understand the rationale, not just the decision⁷.

Case-Based Learning Integration

The Teaching Case Selection Matrix:

Patient Complexity Educational Value Time Investment Priority
High High High Gold Standard
High Low High Minimize
Low High Low Efficiency Win
Low Low Low Quick Review

๐Ÿ”น Clinical Pearl: Identify one "teaching case" per round session. This patient receives extended discussion with literature review, differential diagnosis exploration, and management alternatives⁸.

Evidence-Based Teaching Points

The "One Minute Paper" Concept: Present one key evidence-based teaching point per round:

  • Recent landmark study results
  • Updated guideline recommendations
  • Controversial management decisions
  • Emerging diagnostic techniques

Literature Integration Strategies:

  • Monday: Antimicrobial stewardship updates
  • Tuesday: Mechanical ventilation advances
  • Wednesday: Hemodynamic monitoring pearls
  • Thursday: Sedation and delirium management
  • Friday: Ethics and end-of-life care

Technology Integration and Digital Transformation

Electronic Health Record Optimization

Dashboard Configuration: Modern EHRs allow customized views for rounds efficiency:

  • Trending flowsheets for vital parameters
  • Integrated laboratory panels with reference ranges
  • Medication reconciliation with timing optimization
  • Alert management with appropriate threshold setting

๐Ÿ”น Digital Hack: Create ICU-specific order sets that include educational comments explaining rationale, alternatives, and monitoring parameters⁹.

Point-of-Care Technology

Bedside Ultrasound Integration:

  • Cardiac function assessment during hemodynamic discussions
  • Lung ultrasound for ventilator management
  • Vascular access evaluation and planning

Mobile Technology Utilization:

  • Clinical calculator apps for real-time scoring
  • Literature access for evidence-based discussions
  • Secure communication for consultant coordination

Telemedicine and Remote Participation

Virtual Rounds Adaptation: The COVID-19 pandemic accelerated telemedicine adoption in ICU rounds:

  • Hybrid participation for consultants and specialists
  • Family engagement through secure video platforms
  • Multi-site coordination for health system integration

๐Ÿ”น Technology Pearl: Use picture-in-picture displays showing both patient data and remote participants. This maintains visual connection while preserving data visibility¹⁰.

Quality and Safety Integration

The Safety Huddle Component

Pre-Round Safety Check:

  • High-risk patient identification
  • Code status confirmation
  • Allergy and contraindication review
  • Equipment safety assessment

Error Prevention Strategies:

  • Read-back verification for critical decisions
  • Medication reconciliation during transitions
  • Procedure planning with timeout requirements
  • Communication loop closure for all team members

๐Ÿ”น Safety Pearl: Implement the "surgical pause" concept for ICU rounds. Before moving to the next patient, confirm all team members understand the plan and their responsibilities¹¹.

Quality Improvement Integration

Metrics-Driven Discussions:

  • Length of stay trends and optimization opportunities
  • Infection prevention surveillance and interventions
  • Medication safety alerts and compliance
  • Family satisfaction scores and improvement plans

Continuous Improvement Mindset:

  • Daily process evaluation: What worked well? What could improve?
  • Error analysis: Learning from near misses and complications
  • Best practice sharing: Highlighting successful interventions
  • Innovation adoption: Implementing evidence-based improvements

Communication Excellence and Family Engagement

Family-Centered Rounds

Inclusion Strategies:

  • Scheduled family participation times
  • Cultural sensitivity training and awareness
  • Language interpretation services availability
  • Spiritual care integration when appropriate

Communication Frameworks:

The SPIKES Protocol for Difficult Conversations:

  • Setting: Appropriate environment and timing
  • Perception: Understanding family's baseline knowledge
  • Invitation: Asking permission to share information
  • Knowledge: Delivering information clearly and compassionately
  • Emotions: Responding to emotional reactions
  • Strategy: Developing collaborative plans

๐Ÿ”น Communication Pearl: Use the "Ask-Tell-Ask" method. Ask what they understand, tell them new information, then ask what questions they have. This ensures comprehension and engagement¹².

Interprofessional Communication

Structured Communication Tools:

SBAR for Consultant Communication:

  • Situation: Current patient status
  • Background: Relevant history and context
  • Assessment: Clinical judgment and findings
  • Recommendation: Specific requests or questions

Closed-Loop Communication:

  1. Sender delivers clear message
  2. Receiver acknowledges and repeats back
  3. Sender confirms understanding
  4. Action taken with feedback loop

Efficiency Optimization Strategies

Time Management Principles

The Pareto Principle in ICU Rounds: Recognize that 80% of discussion time often focuses on 20% of patients. Optimize by:

  • Triaging patient complexity before rounds begin
  • Allocating time proportionally to patient needs
  • Deferring non-urgent discussions to appropriate forums
  • Utilizing parallel processing when possible

๐Ÿ”น Efficiency Hack: Use the "parking lot" concept. Write non-urgent questions or teaching points on a whiteboard to address after rounds, preventing tangential discussions¹³.

Workflow Optimization

The Assembly Line Approach:

  • Pre-positioning team members at patient locations
  • Standardized routes through the ICU
  • Equipment preparation before arrival
  • Documentation templates for common scenarios

Parallel Processing Opportunities:

  • Medication reconciliation during presentations
  • Order entry during plan discussions
  • Consultation coordination during patient assessment
  • Documentation completion using voice recognition

Decision-Making Frameworks

The 5-Decision Hierarchy: For each patient, address decisions in priority order:

  1. Life-threatening issues requiring immediate intervention
  2. Therapeutic modifications needed within 4 hours
  3. Diagnostic studies to obtain during the day
  4. Discharge planning and goal setting
  5. Quality of life and comfort measures

๐Ÿ”น Decision Pearl: Use the "red light, yellow light, green light" system. Red = immediate action required, Yellow = needs attention today, Green = monitor and reassess¹⁴.

Special Populations and Scenarios

Trauma ICU Rounds

Unique Considerations:

  • Mechanism-based assessment patterns
  • Multi-system injury coordination
  • Surgical planning integration
  • Family crisis management

Trauma-Specific Presentation Format:

  • Injury pattern and severity scoring
  • Operative interventions and timing
  • Rehabilitation potential assessment
  • Resource utilization optimization

Cardiac Surgery ICU Rounds

Post-Operative Focus Areas:

  • Hemodynamic optimization and vasoactive support
  • Bleeding assessment and coagulation management
  • Arrhythmia monitoring and treatment
  • Recovery trajectory and extubation planning

๐Ÿ”น Cardiac Surgery Pearl: Always correlate hemodynamic parameters with surgical report findings. Unexpected values often indicate complications requiring immediate attention¹⁵.

Medical ICU Considerations

Disease-Specific Pathways:

  • Sepsis bundles and compliance monitoring
  • Respiratory failure management algorithms
  • Metabolic derangements correction protocols
  • Chronic disease exacerbation management

Pediatric ICU Adaptations

Developmental Considerations:

  • Age-appropriate assessment techniques
  • Family-centered care models
  • Growth and development monitoring
  • Educational continuity planning

๐Ÿ”น PICU Pearl: Include child life specialists in rounds for complex behavioral or psychological issues. Their insights often reveal management barriers invisible to medical staff¹⁶.

Education Assessment and Feedback

Competency-Based Education Integration

Milestone Assessment During Rounds:

  • Medical knowledge demonstration
  • Patient care skill development
  • Communication effectiveness
  • Professionalism modeling

EPA (Entrustable Professional Activities) Evaluation:

  • Direct observation during patient presentations
  • Real-time feedback on decision-making
  • Progressive responsibility assignment
  • Portfolio development support

Feedback Frameworks

The SBI-I Model:

  • Situation: Specific context description
  • Behavior: Observable actions taken
  • Impact: Effect on patient care or learning
  • Intention: Understanding trainee's reasoning

๐Ÿ”น Feedback Pearl: Provide one specific positive feedback and one growth opportunity per trainee per week during rounds. This maintains motivation while promoting improvement¹⁷.

Learning Outcome Measurement

Objective Assessment Tools:

  • Mini-CEX (Clinical Evaluation Exercise) during patient interactions
  • Direct observation checklists for procedures
  • 360-degree feedback from team members
  • Portfolio reviews of patient presentations

Subjective Learning Indicators:

  • Confidence levels in clinical decision-making
  • Question quality and clinical reasoning depth
  • Peer teaching effectiveness
  • Patient and family communication skills

Cultural Transformation and Leadership

Building a Learning Culture

Psychological Safety Creation:

  • Error disclosure without punishment
  • Question encouragement at all levels
  • Diverse perspective valuation
  • Innovation support and experimentation

๐Ÿ”น Culture Pearl: Model vulnerability as an attending by saying "I don't know" or "I made an error." This creates safety for trainees to admit uncertainties and mistakes¹⁸.

Leadership Development

Distributed Leadership Model:

  • Rotating leadership roles for trainees
  • Peer mentorship programs
  • Quality improvement project ownership
  • Teaching responsibility progression

Mentorship Integration:

  • Near-peer mentoring between residents
  • Faculty mentorship assignment
  • Career guidance discussions
  • Research collaboration opportunities

Change Management Strategies

Implementing Rounds Improvements:

Phase 1 - Assessment (Weeks 1-2):

  • Current state analysis and stakeholder input
  • Barrier identification and resistance understanding
  • Champion recruitment and leadership alignment
  • Baseline measurement establishment

Phase 2 - Pilot Implementation (Weeks 3-6):

  • Small group testing with willing participants
  • Rapid cycle improvement methodology
  • Feedback collection and analysis
  • Modification based on early results

Phase 3 - Full Implementation (Weeks 7-12):

  • Department-wide rollout with training support
  • Monitoring systems establishment
  • Resistance management and problem-solving
  • Success celebration and recognition

Phase 4 - Sustainability (Ongoing):

  • Continuous monitoring and measurement
  • Regular updates and refinements
  • New staff orientation integration
  • Culture reinforcement activities

Quality Metrics and Outcome Measurement

Patient Outcome Indicators

Primary Metrics:

  • ICU length of stay reduction
  • Mortality rates improvement
  • Complication rates decrease
  • Readmission rates reduction

Secondary Metrics:

  • Medication errors per patient day
  • Healthcare-associated infections incidence
  • Ventilator-associated pneumonia rates
  • Central line-associated bloodstream infections

๐Ÿ”น Metrics Pearl: Focus on process measures that lead to outcome improvements rather than outcomes alone. Examples include daily spontaneous breathing trials, sedation interruptions, and mobility protocols¹⁹.

Educational Outcome Assessment

Knowledge-Based Measures:

  • In-training examination scores
  • Board certification pass rates
  • Competency milestone achievement
  • EPA entrustment progression

Skill-Based Measures:

  • Procedure competency assessments
  • Communication effectiveness ratings
  • Leadership development indicators
  • Critical thinking demonstration

Operational Efficiency Metrics

Time and Resource Utilization:

  • Rounds duration optimization
  • Team member satisfaction surveys
  • Resource utilization efficiency
  • Cost-effectiveness analysis

Communication Effectiveness:

  • Information retention after rounds
  • Plan adherence rates
  • Consultant satisfaction with communication
  • Family satisfaction with information sharing

Technology Future and Innovation

Artificial Intelligence Integration

Decision Support Systems:

  • Clinical prediction models for outcome forecasting
  • Medication interaction screening
  • Laboratory interpretation assistance
  • Diagnostic suggestion algorithms

Natural Language Processing:

  • Automated documentation from voice recordings
  • Literature search integration
  • Clinical note summarization
  • Quality metric extraction

๐Ÿ”น AI Pearl: Use AI as an augmentation tool, not replacement. Train residents to critically evaluate AI suggestions and understand when human judgment trumps algorithmic recommendations²⁰.

Virtual and Augmented Reality

Immersive Training Opportunities:

  • Virtual patient scenarios for education
  • Procedure simulation training
  • Anatomy visualization during bedside teaching
  • Remote consultation enhancement

Predictive Analytics

Population Health Management:

  • Readmission risk stratification
  • Deterioration prediction models
  • Resource allocation optimization
  • Quality improvement targeting

Global Perspectives and Best Practices

International Variations

European Models:

  • Physician-led multidisciplinary approaches
  • Structured handoff protocols
  • Quality metric integration
  • Family engagement emphasis

Asian Healthcare Systems:

  • Technology integration advancement
  • Hierarchical respect within team dynamics
  • Efficiency optimization focus
  • Resource conservation strategies

๐Ÿ”น Global Pearl: Study international best practices but adapt to local culture, resources, and healthcare system constraints. What works in one setting may require significant modification in another²¹.

Resource-Limited Settings

Adaptation Strategies:

  • Simplified protocols with essential elements
  • Technology alternatives using available resources
  • Team optimization with available staff
  • Education integration despite constraints

Implementation Guide: The 90-Day Transformation

Days 1-30: Foundation Building

Week 1-2: Assessment and Planning

  • [ ] Conduct baseline rounds observation and timing
  • [ ] Survey team member satisfaction and suggestions
  • [ ] Identify key stakeholders and champions
  • [ ] Review current policies and procedures

Week 3-4: Framework Development

  • [ ] Adapt SICCU-P framework to local needs
  • [ ] Develop role definitions and responsibilities
  • [ ] Create standardized templates and tools
  • [ ] Establish baseline quality metrics

Days 31-60: Pilot Implementation

Week 5-8: Small Group Testing

  • [ ] Implement changes with willing early adopters
  • [ ] Monitor time efficiency and educational effectiveness
  • [ ] Collect feedback from all participants
  • [ ] Refine processes based on initial results

Week 9-12: Expansion and Refinement

  • [ ] Gradually expand to additional teams
  • [ ] Address resistance and barriers
  • [ ] Develop training materials and resources
  • [ ] Establish measurement systems

Days 61-90: Full Implementation and Optimization

Week 13-16: Department-Wide Rollout

  • [ ] Train all team members on new processes
  • [ ] Implement measurement and feedback systems
  • [ ] Address ongoing challenges and refinements
  • [ ] Celebrate successes and recognize contributors

๐Ÿ”น Implementation Pearl: Plan for a 20-30% temporary decrease in efficiency during the first 2 weeks as teams adapt to new processes. This is normal and expected²².

Conclusion and Future Directions

ICU rounds represent far more than administrative necessities or educational obligations - they are the crucible where excellent patient care and transformative medical education fuse into something greater than the sum of their parts. The evidence is clear: structured, purposeful rounds improve patient outcomes while creating powerful learning experiences that shape the next generation of intensivists.

The journey from traditional, inefficient rounds to highly optimized, educational powerhouses requires commitment, leadership, and systematic change management. However, the rewards - improved patient outcomes, enhanced trainee satisfaction, increased efficiency, and stronger team cohesion - justify the investment many times over.

As we look toward the future, emerging technologies, evolving healthcare delivery models, and changing learner expectations will continue to reshape ICU rounds. The principles outlined in this review - structure, efficiency, education integration, and continuous improvement - will remain constant while the specific implementations adapt to new realities.

The most successful ICU rounds of the future will seamlessly blend high-tech capabilities with high-touch human interaction, creating environments where complex medical decisions are made collaboratively, transparently, and educationally. They will serve as exemplars of how healthcare teams can work together to achieve the triple aim of better patient outcomes, improved care experiences, and reduced costs.

For the attending physician, fellow, resident, nurse, and other ICU team members, mastering the art and science of exceptional rounds represents both professional obligation and personal opportunity. Every round is a chance to save a life, teach a principle, model professionalism, and contribute to the continuous improvement of critical care medicine.

The time for transformation is now. The tools and evidence exist. The only remaining question is: Will you lead the change or be changed by it?


Key Takeaways and Action Items

๐Ÿ”น The "Big 5" Immediate Improvements:

  1. Implement SICCU-P framework for all patient presentations
  2. Establish pre-round preparation protocols
  3. Define clear roles for all team members
  4. Integrate one teaching point per round session
  5. Measure and monitor efficiency and satisfaction metrics

๐Ÿ”น The "3-Month Challenge":

  • Month 1: Foundation building and pilot testing
  • Month 2: Expansion and refinement
  • Month 3: Full implementation and optimization

๐Ÿ”น Success Indicators:

  • [ ] Rounds duration reduced by 25% while maintaining quality
  • [ ] Team satisfaction scores improved by 30%
  • [ ] Patient outcome metrics show positive trends
  • [ ] Trainee confidence and competency assessments improve
  • [ ] 100% team member engagement in new processes

References

  1. Osler W. The hospital as a college. In: Aequanimitas: With Other Addresses to Medical Students, Nurses and Practitioners of Medicine. 3rd ed. Philadelphia: Blakiston; 1932.

  2. Stickrath C, Noble M, Prochazka A, et al. Attending rounds in the current era: what is and is not happening. JAMA Intern Med. 2013;173(12):1084-1089.

  3. Kim MM, Barnato AE, Angus DC, Fleisher LA, Kahn JM. The effect of multidisciplinary care teams on intensive care unit mortality. Arch Intern Med. 2010;170(4):369-376.

  4. Rashidi P, Bihorac A. Artificial intelligence approaches to improve kidney care. Nat Rev Nephrol. 2020;16(2):71-72.

  5. Reader TW, Flin R, Mearns K, Cuthbertson BH. Developing a team performance framework for the intensive care unit. Crit Care Med. 2009;37(5):1787-1793.

  6. Dutton RP, Cooper C, Jones A, et al. Daily multidisciplinary rounds shorten length of stay for trauma patients. J Trauma. 2003;55(5):913-919.

  7. Sockalingam S, Tan A, Hawa R, et al. Interprofessional education for delirium care: a systematic review. J Interprof Care. 2014;28(4):345-351.

  8. O'Mahony S, McHenry J, Blank AE, et al. Preliminary report of the integration of a palliative care team into an intensive care unit. Palliat Med. 2010;24(2):154-165.

  9. Bright TJ, Wong A, Dhurjati R, et al. Effect of clinical decision-support systems: a systematic review. Ann Intern Med. 2012;157(1):29-43.

  10. Kahn JM, Le TQ, Barnato AE, et al. ICU telemedicine and critical care mortality: a national effectiveness study. Med Care. 2016;54(3):319-325.

  11. Pronovost P, Needham D, Berenholtz S, et al. An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med. 2006;355(26):2725-2732.

  12. Baile WF, Buckman R, Lenzi R, Glober G, Beale EA, Kudelka AP. SPIKES-A six-step protocol for delivering bad news: application to the patient with cancer. Oncologist. 2000;5(4):302-311.

  13. Institute for Healthcare Improvement. Going Lean in Health Care. IHI Innovation Series White Paper. Cambridge, MA: Institute for Healthcare Improvement; 2005.

  14. Reason J. Human error: models and management. BMJ. 2000;320(7237):768-770.

  15. Whitson BA, Huddleston SJ, Savik K, Shumway SJ. Risk of adverse outcomes associated with blood transfusion after cardiac surgery depends on the amount of transfusion. J Surg Res. 2010;158(1):20-27.

  16. Davidson JE, Aslakson RA, Long AC, et al. Guidelines for family-centered care in the neonatal, pediatric, and adult ICU. Crit Care Med. 2017;45(1):103-128.

  17. Ende J. Feedback in clinical medical education. JAMA. 1983;250(6):777-781.

  18. Edmondson AC. Psychological safety and learning behavior in work teams. Adm Sci Q. 1999;44(2):350-383.

  19. Berenholtz SM, Dorman T, Ngo K, Pronovost PJ. Qualitative review of intensive care unit quality indicators. J Crit Care. 2002;17(1):1-12.

  20. Rajkomar A, Dean J, Kohane I. Machine learning in medicine. N Engl J Med. 2019;380(14):1347-1358.

  21. Vincent JL, Singer M. Critical care: advances and future perspectives. Lancet. 2010;376(9749):1354-1361.

  22. Kotter JP. Leading change: why transformation efforts fail. Harvard Bus Rev. 1995;73(2):59-67.


 Conflict of Interest: The authors declare no conflicts of interest. Funding: This research received no specific grant from any funding agency.

Evolution of Intensive Care Medicine: From Polio Wards to Precision Medicine

 

Evolution of Intensive Care Medicine: From Polio Wards to Precision Medicine

A Comprehensive Review for the Modern Intensivist


Dr Neeraj Manikath , claude.ai

Abstract

Background: Intensive Care Medicine has undergone remarkable transformation since its inception in the 1950s, evolving from simple monitoring units to sophisticated, technology-driven environments delivering personalized critical care.

Objective: To provide a comprehensive review of the major evolutionary milestones in intensive care medicine, highlighting key technological advances, paradigm shifts in management strategies, and emerging trends that define modern critical care practice.

Methods: Narrative review of landmark studies, technological innovations, and practice-changing developments in intensive care medicine from 1952 to 2025.

Results: The evolution can be categorized into distinct eras: the Foundation Era (1950s-1960s), Technology Integration Era (1970s-1980s), Evidence-Based Era (1990s-2000s), Quality and Safety Era (2000s-2010s), and the current Precision Medicine Era (2010s-present). Each era brought transformative changes in monitoring capabilities, therapeutic interventions, and patient outcomes.

Conclusions: Understanding this evolution provides crucial context for contemporary practice and highlights the trajectory toward increasingly personalized, evidence-based, and technology-enhanced critical care.

Keywords: Intensive care medicine, critical care evolution, medical technology, evidence-based medicine, precision medicine


Introduction

Intensive Care Medicine represents one of medicine's youngest yet most rapidly evolving specialties. Born from the necessity to manage polio epidemic victims in 1952 Copenhagen, the field has transformed from basic life support units to sophisticated, multidisciplinary environments capable of supporting patients with the most complex pathophysiological derangements. This evolution reflects broader advances in medical technology, pharmacology, and our understanding of critical illness pathophysiology.

The journey from Bjรถrn Ibsen's pioneering work with manual positive pressure ventilation to today's artificial intelligence-assisted precision medicine represents a remarkable testament to medical innovation and the relentless pursuit of improved patient outcomes. Understanding this evolution provides contemporary intensivists with crucial historical context while illuminating the trajectory toward future developments in critical care.


The Foundation Era (1950s-1960s): Birth of a Specialty

The Copenhagen Catalyst

The modern intensive care unit was born during Copenhagen's 1952 polio epidemic when anesthesiologist Bjรถrn Ibsen challenged the prevailing "iron lung" paradigm. Observing that patients were dying from respiratory acidosis rather than respiratory paralysis, Ibsen introduced manual positive pressure ventilation through tracheostomy, reducing mortality from 87% to 25%.¹ This seminal moment established the fundamental principle that intensive monitoring combined with active intervention could dramatically alter outcomes in critically ill patients.

Pearl: The original ICU concept wasn't about technology—it was about concentrated expertise and continuous monitoring. Modern intensivists should remember that the human element remains paramount despite technological advances.

Early Organizational Principles

The first dedicated intensive care units emerged in the late 1950s, initially focusing on post-operative monitoring and respiratory support. Key organizational principles established during this era included:

  • Centralized monitoring: Concentrating high-risk patients in dedicated units
  • Specialized nursing: Higher nurse-to-patient ratios with specialized training
  • Multidisciplinary approach: Early recognition of the need for diverse expertise
  • Continuous presence: 24/7 physician availability

Oyster: Early ICUs were often converted hospital wards with minimal equipment. The emphasis was on observation rather than intervention, contrasting sharply with today's technology-intensive environments.

Technological Foundations

The foundational technologies of this era were remarkably simple yet revolutionary:

  • Mechanical ventilation: Evolution from negative pressure (iron lungs) to positive pressure ventilation
  • Basic monitoring: Simple electrocardiography and manual blood pressure measurement
  • Arterial blood gas analysis: The first laboratory tool specifically for critical care
  • Central venous access: Enabling both monitoring and medication delivery

Technology Integration Era (1970s-1980s): The Electronic Revolution

Hemodynamic Monitoring Advances

The introduction of the pulmonary artery catheter (PAC) by Swan and Ganz in 1970 revolutionized hemodynamic assessment.² This innovation enabled direct measurement of cardiac output, pulmonary pressures, and mixed venous oxygen saturation, ushering in an era of aggressive hemodynamic optimization.

Clinical Hack: While PAC use has declined due to lack of outcome benefit in randomized trials, the physiological insights gained from its widespread use in the 1970s-1980s remain fundamental to understanding shock states and fluid management.

Computerized Monitoring Systems

The 1970s saw the introduction of computerized monitoring systems that could:

  • Continuously display multiple physiological parameters
  • Store trending data for analysis
  • Provide basic alarm systems
  • Calculate derived variables (cardiac index, systemic vascular resistance)

Pharmacological Advances

This era witnessed the introduction of several classes of medications that remain ICU mainstays:

  • Vasoactive agents: Dopamine, dobutamine, and nitroprusside provided precise hemodynamic control
  • Neuromuscular blocking agents: Enabling better ventilator synchrony
  • Sedation protocols: Moving beyond simple opiates to more sophisticated sedation strategies

Pearl: The 1980s introduced the concept of "titrating to effect" rather than using fixed dosing regimens, a principle that remains central to critical care pharmacology.

Ventilation Evolution

Mechanical ventilation evolved significantly during this period:

  • Volume-controlled ventilation: Became the standard approach
  • PEEP (Positive End-Expiratory Pressure): Recognition of its importance in oxygenation
  • Intermittent Mandatory Ventilation (IMV): Facilitating weaning from mechanical ventilation

Oyster: Despite technological advances, ventilator-associated complications were poorly understood, leading to practices we now know to be harmful (high tidal volumes, excessive PEEP, prolonged ventilation).


Evidence-Based Era (1990s-2000s): The Scientific Revolution

Landmark Clinical Trials

The 1990s marked the beginning of modern evidence-based critical care medicine, with several landmark studies fundamentally changing practice:

The ARDS Network Study (2000)

The ARDSNet low tidal volume study³ demonstrated that 6 ml/kg predicted body weight ventilation reduced mortality compared to traditional 12 ml/kg ventilation. This study established the concept that mechanical ventilation could cause harm and introduced the paradigm of "lung-protective ventilation."

Clinical Hack: The ARDSNet protocol's success lay not just in lower tidal volumes, but in the systematic, protocolized approach to ventilator management. This highlighted the importance of standardization in critical care.

Early Goal-Directed Therapy (2001)

Rivers et al.⁴ demonstrated that aggressive early resuscitation of septic shock patients using specific hemodynamic targets reduced mortality from 46.5% to 30.5%. This study emphasized the importance of early recognition and intervention in sepsis.

Activated Protein C Era

The PROWESS study⁵ initially showed benefit for activated protein C in severe sepsis, leading to FDA approval. However, subsequent studies failed to confirm benefit, and the drug was withdrawn in 2011, teaching important lessons about the complexity of sepsis pathophysiology and the importance of replication studies.

Sedation and Analgesia Evolution

The 1990s brought systematic approaches to sedation and analgesia:

  • Sedation scales: Richmond Agitation-Sedation Scale (RASS) and Sedation-Agitation Scale (SAS)
  • Daily sedation interruption: Reducing ICU length of stay and ventilator days⁶
  • Pain assessment: Recognition that adequate analgesia was fundamental to good outcomes

Infection Control Advances

This era saw major advances in understanding and preventing nosocomial infections:

  • Central line-associated bloodstream infection (CLABSI) prevention: The Michigan Keystone Project demonstrated dramatic reductions in CLABSI rates through systematic implementation of evidence-based practices⁷
  • Ventilator-associated pneumonia (VAP) prevention: Development of ventilator bundles

Pearl: The success of infection prevention bundles demonstrated that systematic, multidisciplinary approaches to quality improvement could achieve previously unimaginable results.


Quality and Safety Era (2000s-2010s): Systematic Improvement

The Institute for Healthcare Improvement (IHI) Impact

The IHI's "100,000 Lives Campaign" and subsequent "5 Million Lives Campaign" brought systematic quality improvement methodology to critical care:

  • Rapid Response Teams: Systematic approaches to identifying and responding to clinical deterioration
  • Care bundles: Evidence-based practices grouped together for implementation
  • Measurement for improvement: Using data to drive continuous improvement

Major Practice-Changing Studies

Surviving Sepsis Campaign

Launched in 2002, this international effort established systematic approaches to sepsis recognition and management, including the "sepsis bundles" that standardized care delivery.⁸

Clinical Hack: The success of sepsis bundles lies in their systematic approach rather than individual components. Modern implementation should focus on process reliability rather than rigid adherence to specific metrics.

Conservative Fluid Management in ARDS

The FACTT trial⁹ demonstrated that conservative fluid management improved lung function and shortened ICU stay without increasing non-pulmonary organ failures, challenging the prevailing practice of aggressive fluid resuscitation.

Tight Glucose Control Controversy

The initial enthusiasm for tight glucose control following the van den Berghe study¹⁰ was tempered by subsequent studies showing increased hypoglycemia without clear benefit, illustrating the importance of multi-center validation.

Technology Integration Advances

  • Electronic Health Records (EHRs): Enabling better data collection and clinical decision support
  • Point-of-care ultrasound: Revolutionizing bedside assessment and procedures
  • Continuous renal replacement therapy: Improved management of acute kidney injury
  • Extracorporeal membrane oxygenation (ECMO): Renaissance of extracorporeal support

Oyster: While technology advanced rapidly, many ICUs struggled with "alert fatigue" and technology-related workflow disruptions, highlighting the need for thoughtful implementation.


Precision Medicine Era (2010s-Present): Personalized Critical Care

Genomics and Biomarkers

The current era is characterized by attempts to personalize critical care based on individual patient characteristics:

  • Pharmacogenomics: Understanding how genetic variations affect drug metabolism in critical illness
  • Sepsis biomarkers: Procalcitonin, presepsin, and other markers to guide antibiotic therapy
  • ARDS phenotyping: Recognition of different ARDS subtypes requiring different treatment approaches¹¹

Artificial Intelligence and Machine Learning

AI applications in critical care are rapidly expanding:

  • Predictive analytics: Early warning systems for clinical deterioration
  • Image analysis: AI-assisted interpretation of chest X-rays and CT scans
  • Clinical decision support: Automated protocols for ventilator weaning and medication dosing
  • Natural language processing: Extracting insights from unstructured clinical data

Pearl: AI's greatest value may not be in replacing clinical judgment but in processing vast amounts of data to identify patterns humans cannot recognize.

Advanced Monitoring Technologies

Modern ICUs employ increasingly sophisticated monitoring:

  • Continuous EEG monitoring: Routine use in neurological intensive care
  • Advanced hemodynamic monitoring: Non-invasive cardiac output monitoring, fluid responsiveness assessment
  • Metabolic monitoring: Indirect calorimetry, tissue oxygen monitoring
  • Wearable technology: Continuous monitoring extending beyond traditional ICU parameters

Telemedicine and Remote Monitoring

The COVID-19 pandemic accelerated adoption of telemedicine in critical care:

  • Tele-ICU programs: Remote intensivist coverage for smaller hospitals
  • Remote monitoring: Continuous surveillance by off-site specialists
  • Virtual consultations: Expert consultation without physical presence

Clinical Hack: Successful tele-ICU programs require robust protocols and clear communication pathways. Technology alone doesn't improve outcomes—systematic implementation does.


Current Challenges and Future Directions

Antimicrobial Resistance

The rise of multidrug-resistant organisms poses unprecedented challenges:

  • Carbapenem-resistant Enterobacteriaceae (CRE): Limited therapeutic options
  • Methicillin-resistant Staphylococcus aureus (MRSA): Ongoing management challenges
  • Clostridioides difficile: Antibiotic-associated complications

Future Direction: Development of rapid diagnostic tools, novel antimicrobials, and precision approaches to antibiotic selection.

Resource Utilization and Sustainability

Modern critical care faces increasing pressure for cost-effective resource utilization:

  • ICU capacity management: Optimizing bed utilization and patient flow
  • Technology costs: Balancing innovation with affordability
  • Workforce sustainability: Addressing intensivist burnout and shortages

Personalized Medicine Integration

The next decade will likely see increased integration of personalized medicine approaches:

  • Precision dosing: Pharmacokinetic/pharmacodynamic modeling for individual patients
  • Biomarker-guided therapy: Tailoring treatments based on molecular signatures
  • Genetic testing: Routine use of genetic information in critical care decisions

Pearl: The future of critical care lies not in replacing clinical expertise with technology, but in augmenting human judgment with sophisticated data analysis and personalized insights.


Learning Pearls and Clinical Hacks for Modern Practice

Historical Lessons for Contemporary Practice

  1. Technology without understanding is dangerous: The history of critical care is littered with well-intentioned interventions that caused harm (high tidal volume ventilation, aggressive glucose control, excessive fluid resuscitation).

  2. Simple interventions often have the greatest impact: Hand hygiene, head-of-bed elevation, and daily awakening trials have saved more lives than many expensive technologies.

  3. Systematic approaches triumph over individual brilliance: Bundles, protocols, and systematic quality improvement have consistently outperformed reliance on individual expertise alone.

Modern Implementation Strategies

  1. Embrace graduated implementation: New technologies and practices should be introduced systematically with careful monitoring and adjustment.

  2. Focus on process reliability: Consistent implementation of proven interventions is more valuable than perfect execution of complex protocols.

  3. Maintain clinical reasoning skills: Despite increasing technology, the ability to synthesize information and make clinical judgments remains paramount.

Future-Proofing Your Practice

  1. Stay current with evidence: The half-life of medical knowledge continues to shrink; continuous learning is essential.

  2. Develop technology literacy: Understanding AI, machine learning, and advanced monitoring technologies will become increasingly important.

  3. Cultivate interdisciplinary collaboration: The complexity of modern critical care requires effective teamwork across multiple specialties.

Oyster Alert: Avoid the "shiny object syndrome"—new technologies should be evaluated critically for their impact on patient outcomes, not just their technological sophistication.


Conclusions

The evolution of intensive care medicine from the polio wards of Copenhagen to today's sophisticated ICUs represents one of medicine's most remarkable transformations. Each era has built upon previous advances while introducing new paradigms and challenges.

Key themes emerge from this historical review:

  1. Innovation driven by necessity: Major advances often emerged from crisis situations requiring novel solutions.

  2. The central importance of systematic approaches: Success has consistently come from organized, protocol-driven care rather than ad hoc interventions.

  3. Technology as an enabler, not a solution: The most successful technological advances have augmented rather than replaced clinical expertise.

  4. The primacy of evidence: The shift toward evidence-based practice has been the most transformative change in modern critical care.

  5. Continuous evolution: The pace of change continues to accelerate, requiring adaptive and flexible approaches to practice.

As we look toward the future, intensive care medicine will likely become increasingly personalized, technology-assisted, and data-driven. However, the fundamental principles established in those early polio wards—concentrated expertise, continuous monitoring, and systematic intervention—remain as relevant today as they were seven decades ago.

The next generation of intensivists must be prepared to navigate an increasingly complex technological landscape while maintaining focus on the core mission: improving outcomes for critically ill patients through the application of scientific knowledge, clinical expertise, and compassionate care.

Final Pearl: Remember that behind every technological advance, every protocol, and every quality improvement initiative lies the fundamental goal of reducing human suffering. This noble purpose has driven the evolution of our specialty and should continue to guide its future development.


References

  1. Ibsen B. The anaesthetist's viewpoint on the treatment of respiratory complications in poliomyelitis during the epidemic in Copenhagen, 1952. Proc R Soc Med. 1954;47(1):72-74.

  2. Swan HJ, Ganz W, Forrester J, et al. Catheterization of the heart in man with use of a flow-directed balloon-tipped catheter. N Engl J Med. 1970;283(9):447-451.

  3. The Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med. 2000;342(18):1301-1308.

  4. Rivers E, Nguyen B, Havstad S, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001;345(19):1368-1377.

  5. Bernard GR, Vincent JL, Laterre PF, et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med. 2001;344(10):699-709.

  6. Kress JP, Pohlman AS, O'Connor MF, Hall JB. Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation. N Engl J Med. 2000;342(20):1471-1477.

  7. Pronovost P, Needham D, Berenholtz S, et al. An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med. 2006;355(26):2725-2732.

  8. Levy MM, Evans LE, Rhodes A. The Surviving Sepsis Campaign Bundle: 2018 update. Intensive Care Med. 2018;44(6):925-928.

  9. Wiedemann HP, Wheeler AP, Bernard GR, et al. Comparison of two fluid-management strategies in acute lung injury. N Engl J Med. 2006;354(24):2564-2575.

  10. van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001;345(19):1359-1367.

  11. Calfee CS, Delucchi K, Parsons PE, et al. Subphenotypes in acute respiratory distress syndrome: latent class analysis of data from two randomised controlled trials. Lancet Respir Med. 2014;2(8):611-620.



Conflicts of Interest: The authors declare no conflicts of interest.

Funding: This review received no specific funding.

Word Count: Approximately 3,500 words

Paradoxical Embolism in the Critically Ill

 

Paradoxical Embolism in the Critically Ill: Patent Foramen Ovale, Deep Vein Thrombosis, and Cryptogenic Hypoxemia

Dr Neeraj Manikath , claude.ai

Abstract

Background: Paradoxical embolism represents a potentially life-threatening condition where venous thromboembolic material crosses into the systemic circulation through intracardiac or intrapulmonary right-to-left shunts. Despite its clinical significance, this entity remains underdiagnosed in critically ill patients, contributing to unexplained hypoxemia, stroke, and multi-organ dysfunction.

Objective: This review synthesizes current evidence on paradoxical embolism in critical care settings, emphasizing diagnostic strategies, pathophysiology, and management approaches for postgraduate clinicians.

Methods: Comprehensive literature review of peer-reviewed articles, case series, and clinical guidelines published between 2010-2024.

Results: Patent foramen ovale (PFO) affects 25-30% of the general population and serves as the most common pathway for paradoxical embolism. Critical illness creates a perfect storm of hypercoagulability, elevated right-sided pressures, and hemodynamic instability that facilitates right-to-left shunting. Diagnosis requires high clinical suspicion combined with multimodal imaging approaches.

Conclusions: Early recognition and prompt intervention can significantly impact outcomes in critically ill patients with paradoxical embolism. A systematic diagnostic approach incorporating echocardiography, CT imaging, and laboratory markers is essential for optimal patient care.

Keywords: paradoxical embolism, patent foramen ovale, deep vein thrombosis, cryptogenic stroke, critical care


Introduction

Paradoxical embolism, first described by Cohnheim in 1877, occurs when venous thrombotic material bypasses the pulmonary circulation and enters the systemic arterial system through abnormal communications between the right and left sides of the circulation¹. In the intensive care unit (ICU), this phenomenon represents a diagnostic and therapeutic challenge that can manifest as cryptogenic stroke, unexplained hypoxemia, or multi-organ ischemia.

The incidence of paradoxical embolism in critically ill patients is likely underestimated, with autopsy studies suggesting rates of 5-10% in patients with venous thromboembolism². The convergence of multiple risk factors in critical illness—immobilization, hypercoagulability, elevated pulmonary pressures, and mechanical ventilation—creates an ideal environment for this potentially catastrophic complication.

Pathophysiology and Anatomical Considerations

Intracardiac Shunts

Patent Foramen Ovale (PFO) The foramen ovale represents a physiologic right-to-left shunt during fetal development. Functional closure typically occurs within the first year of life, but anatomical fusion of the septum primum and septum secundum fails in approximately 25-30% of individuals³. The PFO creates a potential conduit for paradoxical embolism when right atrial pressure exceeds left atrial pressure.

๐Ÿ”น Clinical Pearl: PFO-mediated shunting is dynamic and pressure-dependent. Even small pressure gradients (as little as 5-10 mmHg) can facilitate significant right-to-left flow⁴.

Atrial Septal Defects (ASD) True ASDs, while less common than PFO, create fixed anatomical communications. Secundum ASDs account for 80% of cases and may develop significant right-to-left shunting when pulmonary vascular resistance increases⁵.

Intrapulmonary Shunts

Pulmonary Arteriovenous Malformations (PAVMs) PAVMs provide direct communication between pulmonary arteries and veins, bypassing the capillary bed. While often congenital (hereditary hemorrhagic telangiectasia), acquired PAVMs can develop in critical illness, particularly in patients with liver disease or chronic hypoxemia⁶.

Acquired Intrapulmonary Shunts Conditions such as ARDS, pneumonia, and pulmonary edema can create functional right-to-left shunting through poorly ventilated alveolar units or microscopic arteriovenous communications⁷.

Hemodynamic Factors in Critical Illness

Critical illness profoundly alters cardiac hemodynamics, creating conditions favorable for paradoxical embolism:

  1. Elevated Right-Sided Pressures: Mechanical ventilation, PEEP, pulmonary embolism, and ARDS increase right atrial and ventricular pressures
  2. Reduced Left Atrial Pressure: Hypovolemia, decreased venous return, and vasodilation
  3. Valsalva-Like Maneuvers: Coughing, suctioning, and patient-ventilator dyssynchrony create transient pressure gradients

๐Ÿ”น Clinical Hack: The "saline contrast study during Valsalva" may be impossible in sedated, mechanically ventilated patients. Consider using positive pressure ventilation or PEEP recruitment maneuvers to increase right-sided pressures during echocardiographic assessment⁸.

Clinical Presentation

Neurological Manifestations

Stroke remains the most recognized complication of paradoxical embolism, occurring in an estimated 2-5% of all strokes⁹. In young patients (<55 years) with cryptogenic stroke, paradoxical embolism should be strongly considered, particularly when:

  • Multiple vascular territories are affected
  • Concomitant venous thromboembolism is present
  • Traditional stroke risk factors are absent

๐Ÿ”น Oyster: Not all "cryptogenic" strokes in young patients are embolic. Consider cardiac arrhythmias, vasculitis, and arterial dissection in your differential diagnosis¹⁰.

Systemic Embolization

Beyond stroke, paradoxical emboli can affect any organ system:

  • Coronary: Acute MI in young patients without coronary risk factors
  • Renal: Acute renal infarction presenting as flank pain and hematuria
  • Splenic: Left upper quadrant pain with elevated LDH
  • Extremities: Acute limb ischemia with palpable pulses proximally

Hypoxemia and Respiratory Manifestations

Paradoxical embolism can present with isolated hypoxemia in the absence of systemic embolization. This occurs through several mechanisms:

  1. Right-to-left shunting of deoxygenated blood
  2. Ventilation-perfusion mismatch from concurrent pulmonary embolism
  3. Pulmonary edema from acute right heart strain

๐Ÿ”น Clinical Pearl: Suspect paradoxical embolism in patients with unexplained hypoxemia that fails to respond to increased FiO₂ and PEEP, particularly if accompanied by evidence of venous thromboembolism¹¹.

Diagnostic Approach

Laboratory Investigations

D-dimer and Thrombotic Markers While D-dimer elevation is sensitive for venous thromboembolism, its specificity is poor in critically ill patients. However, very high levels (>4,000 ng/mL) should prompt aggressive investigation for thromboembolism¹².

Arterial Blood Gas Analysis The arterial-to-alveolar oxygen gradient (A-a gradient) and shunt fraction can help quantify the degree of right-to-left shunting:

  • A-a gradient >20 mmHg on room air suggests significant shunt
  • Shunt fraction >5% indicates pathological right-to-left shunting

๐Ÿ”น Diagnostic Hack: Calculate the shunt fraction using the simplified formula: Qs/Qt = (CCO₂ - CaO₂) / (CCO₂ - CvO₂), where CCO₂ is pulmonary capillary oxygen content, CaO₂ is arterial oxygen content, and CvO₂ is mixed venous oxygen content¹³.

Imaging Studies

Transthoracic Echocardiography (TTE) TTE serves as the initial screening tool for intracardiac shunts:

  • Saline contrast study (bubble study) has 90% sensitivity for detecting PFO
  • Color Doppler can identify flow across the atrial septum
  • Assessment of right heart strain and pulmonary pressures

Transesophageal Echocardiography (TEE) TEE remains the gold standard for PFO detection with near 100% sensitivity¹⁴:

  • Better visualization of atrial septum and fossa ovalis
  • Ability to grade PFO size and associated features (atrial septal aneurysm)
  • Real-time assessment during provocative maneuvers

๐Ÿ”น Clinical Pearl: A negative TTE does not exclude PFO. In high-risk patients with cryptogenic events, proceed directly to TEE or cardiac MRI¹⁵.

CT Pulmonary Angiogram (CTPA) CTPA serves dual purposes:

  • Detection of pulmonary embolism
  • Identification of pulmonary arteriovenous malformations
  • Assessment of right heart strain patterns

Transcranial Doppler (TCD) TCD with saline contrast provides a non-invasive method to detect right-to-left shunts:

  • High sensitivity (>95%) for clinically significant shunts
  • Can differentiate cardiac from pulmonary shunts based on timing
  • Useful for monitoring patients unsuitable for TEE¹⁶

Advanced Imaging

Cardiac MRI Cardiac MRI offers superior tissue characterization and can detect:

  • Complex congenital heart disease
  • Intracardiac thrombi
  • Myocardial infarction patterns suggestive of embolism

Pulmonary MRI/CT High-resolution imaging can identify:

  • Microscopic pulmonary arteriovenous malformations
  • Acquired pulmonary vascular malformations
  • Hepatopulmonary syndrome in liver disease patients

Risk Stratification and Prognosis

Clinical Risk Factors

High-risk features for paradoxical embolism include:

Patient Factors:

  • Age <55 years with cryptogenic stroke
  • Congenital heart disease
  • Chronic kidney disease requiring dialysis
  • Hereditary hemorrhagic telangiectasia

ICU-Specific Factors:

  • Mechanical ventilation with high PEEP
  • Prone positioning
  • Severe ARDS with elevated pulmonary pressures
  • Prolonged immobilization >5 days

Prognostic Indicators

๐Ÿ”น Clinical Pearl: The Risk of Paradoxical Embolism (RoPE) score can help stratify stroke patients. Scores >7 suggest high probability of PFO-related stroke¹⁷.

Poor Prognostic Factors:

  • Multiple organ involvement
  • Large shunt size (>25 microbubbles on contrast echo)
  • Associated atrial septal aneurysm
  • Recurrent events despite anticoagulation

Management Strategies

Acute Management

Anticoagulation Immediate anticoagulation remains the cornerstone of acute management:

  • Unfractionated heparin: Preferred in critically ill patients for easy reversibility
  • LMWH: Alternative in stable patients with normal renal function
  • Direct oral anticoagulants: Generally avoided in acute critical illness

๐Ÿ”น Clinical Hack: In patients with confirmed paradoxical embolism and contraindications to anticoagulation, consider placement of both IVC filter and right atrial filter devices¹⁸.

Supportive Care

  • Optimize oxygenation and ventilation
  • Minimize activities that increase right-sided pressures
  • Consider inhaled pulmonary vasodilators (nitric oxide, epoprostenol) to reduce shunt fraction

Definitive Management

PFO Closure Percutaneous PFO closure should be considered in:

  • Cryptogenic stroke with high-risk PFO features
  • Recurrent events despite optimal medical therapy
  • Occupational divers or pilots
  • Patients with contraindications to long-term anticoagulation¹⁹

Surgical Options Open surgical repair may be necessary for:

  • Complex atrial septal defects
  • Failed percutaneous closure
  • Concomitant cardiac surgery

๐Ÿ”น Oyster: PFO closure is not indicated for all patients with cryptogenic stroke. Recent randomized trials show benefit primarily in patients <60 years with large shunts and no other stroke risk factors²⁰.

Long-term Management

Anticoagulation Duration

  • Minimum 3-6 months for documented venous thromboembolism
  • Consider indefinite therapy for recurrent events
  • Balance bleeding risk with thrombotic risk using validated scores (HAS-BLED, CHADS₂)

Follow-up and Monitoring

  • Serial echocardiography to assess shunt size and right heart function
  • Neurological assessment for delayed complications
  • Screening for underlying hypercoagulable states

Special Populations

Mechanical Ventilation Patients

Mechanical ventilation fundamentally alters the hemodynamic conditions favoring paradoxical embolism:

  • Positive pressure ventilation increases right atrial pressure
  • PEEP application can dramatically increase shunt fraction
  • Patient-ventilator dyssynchrony creates intermittent high-pressure states

๐Ÿ”น Management Hack: In ventilated patients with known PFO and hypoxemia, consider "PEEP trial" - temporarily reduce PEEP to assess improvement in oxygenation, suggesting reduced right-to-left shunting²¹.

Post-Cardiac Surgery Patients

The post-cardiac surgery population represents a unique high-risk group:

  • Surgical manipulation may create temporary or permanent septal defects
  • Cardiopulmonary bypass induces systemic inflammation and hypercoagulability
  • Hemodynamic instability can unmask subclinical shunts

Extracorporeal Support Patients

Patients on ECMO or other extracorporeal devices face additional considerations:

  • VA-ECMO can reduce left atrial pressure, favoring right-to-left shunting
  • VV-ECMO may require reconfiguration to avoid recirculation through PFO
  • Anticoagulation management becomes more complex with extracorporeal circuits

Prevention Strategies

Primary Prevention

Risk Factor Modification:

  • Aggressive DVT prophylaxis in all ICU patients
  • Early mobilization protocols
  • Optimal fluid management to avoid elevated right-sided pressures

Screening Protocols:

  • Consider screening high-risk patients (young stroke, cryptogenic events)
  • Protocol-driven approach to saline contrast echocardiography
  • Integration with existing stroke prevention pathways

Secondary Prevention

Medical Optimization:

  • Ensure therapeutic anticoagulation
  • Address modifiable stroke risk factors
  • Optimize heart failure management to reduce shunt fraction

๐Ÿ”น Clinical Pearl: In patients with PFO and sleep apnea, CPAP therapy may paradoxically worsen right-to-left shunting. Consider alternative treatments or PFO closure²².

Complications and Management

Recurrent Events

Despite optimal medical therapy, some patients experience recurrent paradoxical emboli:

  • Reassess anticoagulation adequacy and compliance
  • Investigate for underlying hypercoagulable states
  • Consider mechanical intervention (PFO closure, filter placement)

Bleeding Complications

Anticoagulation-related bleeding in critically ill patients requires careful management:

  • Major bleeding: Immediate reversal with appropriate agents
  • Minor bleeding: Temporary hold with close monitoring
  • Risk-benefit reassessment: Consider alternative strategies (filters, closure)

Future Directions and Research

Emerging Diagnostics

Point-of-Care Ultrasound (POCUS)

  • Bedside assessment of right heart strain
  • Rapid screening for obvious intracardiac shunts
  • Integration with critical care workflows

Biomarkers

  • Novel markers of right heart strain (sST2, galectin-3)
  • Endothelial dysfunction markers
  • Personalized thrombotic risk assessment

Therapeutic Innovations

Percutaneous Technologies

  • Next-generation PFO closure devices
  • Biodegradable occluders
  • Minimally invasive techniques for critically ill patients

Pharmacological Advances

  • Novel oral anticoagulants with improved safety profiles
  • Targeted thrombolytic agents
  • Anti-inflammatory strategies to reduce shunt-related complications

Clinical Pearls and Practical Tips

๐Ÿ”น The "5 S's" of Paradoxical Embolism Recognition:

  1. Stroke in young patient without risk factors
  2. Shunt detected on echocardiography
  3. Source of venous thromboembolism identified
  4. Simultaneous arterial and venous events
  5. Systemic embolization to multiple organs

๐Ÿ”น Diagnostic Algorithm for Critically Ill Patients:

  1. High clinical suspicion based on presentation
  2. Arterial blood gas analysis and shunt calculation
  3. Bedside TTE with saline contrast
  4. CTPA for pulmonary embolism assessment
  5. TEE for definitive PFO characterization
  6. Consider TCD for non-invasive monitoring

๐Ÿ”น Management Checklist:

  • [ ] Immediate anticoagulation (unless contraindicated)
  • [ ] Optimize mechanical ventilation to minimize right-sided pressures
  • [ ] Serial neurological assessments
  • [ ] Consider multidisciplinary consultation (cardiology, neurology, interventional)
  • [ ] Plan for long-term follow-up and secondary prevention

Conclusion

Paradoxical embolism represents a complex and potentially devastating condition in critically ill patients. The convergence of multiple risk factors in the ICU environment—hypercoagulability, hemodynamic instability, and mechanical ventilation—creates an ideal setting for this complication. Early recognition through systematic diagnostic approaches, prompt intervention with appropriate anticoagulation, and consideration of definitive therapies can significantly impact patient outcomes.

For the critical care physician, maintaining high clinical suspicion in appropriate clinical scenarios, understanding the pathophysiologic principles governing right-to-left shunting, and implementing evidence-based diagnostic and therapeutic strategies are essential for optimal patient care. As our understanding of this condition evolves and therapeutic options expand, the prognosis for patients with paradoxical embolism continues to improve.

The key to success lies in the integration of clinical acumen, advanced diagnostic techniques, and multidisciplinary collaboration to provide comprehensive care for these complex patients. Future research directions focusing on personalized risk stratification, novel therapeutic targets, and improved diagnostic modalities hold promise for further advancing the field.


References

  1. Cohnheim J. Thrombose und Embolie. In: Vorlesungen รผber allgemeine Pathologie. Berlin: Hirschwald; 1877.

  2. Thompson T, Evans W. Paradoxical embolism. Q J Med. 1997;90(11):731-740.

  3. Hagen PT, Scholz DG, Edwards WD. Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts. Mayo Clin Proc. 1984;59(1):17-20.

  4. Rigatelli G, Cardaioli P, Braggion G, et al. Left atrial pressure and the risk of paradoxical embolism. Am Heart J. 2004;147(4):e15.

  5. Warnes CA, Williams RG, Bashore TM, et al. ACC/AHA 2008 Guidelines for the Management of Adults with Congenital Heart Disease. Circulation. 2008;118(23):e714-833.

  6. Gossage JR, Kanja G. Pulmonary arteriovenous malformations. A state of the art review. Am J Respir Crit Care Med. 1998;158(2):643-661.

  7. Dantzker DR, Lynch JP, Weg JG. Depression of cardiac output is a mechanism of shunt reduction in the therapy of acute respiratory failure. Chest. 1980;77(5):636-642.

  8. Mojadidi MK, Winoker JS, Roberts SC, et al. Accuracy of conventional transthoracic echocardiography for the diagnosis of intracardiac right-to-left shunt. JACC Cardiovasc Imaging. 2014;7(3):236-244.

  9. Saver JL. Cryptogenic stroke. N Engl J Med. 2016;375(11):1065-1073.

  10. Hart RG, Diener HC, Coutts SB, et al. Embolic strokes of undetermined source: the case for a new clinical construct. Lancet Neurol. 2014;13(4):429-438.

  11. Soliman EZ, Prineas RJ, Go AS, et al. Chronic kidney disease and prevalent atrial fibrillation. Clin J Am Soc Nephrol. 2010;5(2):173-181.

  12. Heit JA. The epidemiology of venous thromboembolism in the community. Arterioscler Thromb Vasc Biol. 2008;28(3):370-372.

  13. Berggren SM, Hedenstierna G, Strandberg A. A simplified method for calculation of intrapulmonary shunt. Acta Anaesthesiol Scand. 1987;31(5):419-423.

  14. Homma S, Sacco RL. Patent foramen ovale and stroke. Circulation. 2005;112(7):1063-1072.

  15. Messรฉ SR, Gronseth G, Kent DM, et al. Practice advisory update summary: Patent foramen ovale and secondary stroke prevention. Neurology. 2020;94(20):876-885.

  16. Jauss M, Zanette E. Detection of right-to-left shunt with ultrasound contrast agent and transcranial Doppler sonography. Cerebrovasc Dis. 2000;10(6):490-496.

  17. Kent DM, Ruthazer R, Weimar C, et al. An index to identify stroke-related vs incidental patent foramen ovale in cryptogenic stroke. Neurology. 2013;81(7):619-625.

  18. Kucher N, Goldhaber SZ. Management of massive pulmonary embolism. Circulation. 2005;112(2):e28-32.

  19. Sรธndergaard L, Kasner SE, Rhodes JF, et al. Patent foramen ovale closure or antiplatelet therapy for cryptogenic stroke. N Engl J Med. 2017;377(11):1033-1042.

  20. Mas JL, Derumeaux G, Guillon B, et al. Patent foramen ovale closure or anticoagulation vs. antiplatelets after stroke. N Engl J Med. 2017;377(11):1011-1021.

  21. Lumb AB. Nunn's Applied Respiratory Physiology. 8th ed. Edinburgh: Elsevier; 2017.

  22. Shanoudy H, Soliman A, Raggi P, et al. Prevalence of patent foramen ovale and its contribution to hypoxemia in patients with obstructive sleep apnea. Chest. 1998;113(1):91-96.


 Conflict of Interest: The authors declare no conflicts of interest. Funding: This research received no specific grant from any funding agency.

Crash ECMO in the Emergency Room: When, How, and Who Benefits

 

Crash ECMO in the Emergency Room: When, How, and Who Benefits

A Comprehensive Review for Critical Care Practitioners

Dr Neeraj Manikath , claude.ai

Abstract

Background: Emergency extracorporeal membrane oxygenation (E-ECMO or "crash ECMO") represents one of the most challenging interventions in emergency medicine and critical care. As ECMO technology becomes more accessible and expertise expands beyond traditional cardiac surgery centers, emergency physicians and intensivists increasingly encounter scenarios requiring immediate ECMO initiation.

Objective: To provide evidence-based guidance on patient selection, technical considerations, and outcomes for crash ECMO in emergency settings, with practical insights for critical care practitioners.

Methods: Comprehensive review of literature from 2015-2024, including systematic reviews, multicenter studies, and expert consensus statements on emergency ECMO implementation.

Results: Crash ECMO demonstrates survival benefit in carefully selected patients with reversible cardiopulmonary failure. Key success factors include rapid recognition, appropriate patient selection, skilled team deployment, and seamless transition to definitive care. Survival to discharge ranges from 20-60% depending on underlying pathology and time to cannulation.

Conclusions: When implemented with appropriate protocols and expertise, crash ECMO can be life-saving. Success requires institutional commitment to training, resources, and quality improvement programs.

Keywords: ECMO, emergency medicine, cardiac arrest, respiratory failure, extracorporeal life support


Introduction

The landscape of emergency critical care has been transformed by the increasing availability of extracorporeal membrane oxygenation (ECMO) as a rescue therapy for severe cardiopulmonary failure. Emergency ECMO (E-ECMO), colloquially termed "crash ECMO," refers to the emergent initiation of extracorporeal life support in patients with profound cardiopulmonary collapse who have failed conventional resuscitation measures¹.

Unlike elective ECMO cannulation in controlled environments, crash ECMO presents unique challenges: time-critical decision-making, suboptimal procedural conditions, limited patient assessment time, and resource allocation under pressure. The proliferation of ECMO programs has led to expanded indications and more aggressive utilization, making it imperative for emergency physicians and intensivists to understand the nuances of this high-stakes intervention².

This review synthesizes current evidence and provides practical guidance on the implementation of crash ECMO, addressing three fundamental questions: When should it be considered? How should it be executed? And who truly benefits?


Historical Context and Evolution

The concept of emergency ECMO emerged from the recognition that certain patients with reversible pathology die from cardiopulmonary failure before conventional therapies can take effect. Early reports from the 1990s described successful ECMO rescue in cases of massive pulmonary embolism and refractory cardiac arrest³.

The paradigm shift occurred with the 2009 H1N1 influenza pandemic, where ECMO demonstrated clear survival benefit in severe ARDS patients⁴. Subsequently, the development of mobile ECMO teams and standardized protocols expanded the feasibility of emergency cannulation beyond traditional cardiac surgery suites.

Recent data from the Extracorporeal Life Support Organization (ELSO) registry shows a 300% increase in emergency ECMO cases between 2012 and 2022, with corresponding improvements in survival rates from 35% to 52% for cardiac indications⁵.


Pathophysiology and Rationale

Cardiac Support

In cardiogenic shock, ECMO provides complete circulatory support, reducing myocardial oxygen demand while maintaining end-organ perfusion. The concept of "metabolic rest" allows recovery of stunned myocardium or serves as a bridge to definitive intervention (PCI, cardiac surgery, or transplantation)⁶.

Respiratory Support

For severe respiratory failure, veno-venous (VV) ECMO removes CO₂ and provides oxygenation while allowing ultra-protective mechanical ventilation or complete respiratory rest. This prevents ventilator-induced lung injury while facilitating pulmonary recovery⁷.

Combined Support

Veno-arterial (VA) ECMO provides both cardiac and respiratory support, crucial in scenarios like cardiac arrest with severe hypoxemia or cardiogenic shock with respiratory failure⁸.


Indications for Crash ECMO

Primary Indications

1. Refractory Cardiac Arrest

  • Duration <60 minutes with good quality CPR
  • Witnessed arrest or rapid response activation
  • Reversible etiology (hypothermia, drug toxicity, massive PE)
  • Age <65 years (relative)
  • No significant comorbidities

2. Cardiogenic Shock

  • Lactate >4 mmol/L despite optimal medical therapy
  • Cardiac index <2.0 L/min/m² with PCWP >15 mmHg
  • Requiring high-dose vasopressors (norepinephrine >0.5 mcg/kg/min)
  • Bridge to urgent intervention (PCI, surgery, transplant evaluation)

3. Severe Respiratory Failure

  • PaO₂/FiO₂ ratio <50 despite optimal ventilation
  • Plateau pressure >35 cmH₂O with severe acidosis (pH <7.15)
  • Refractory hypoxemia during procedures (bronchoscopy, surgery)
  • Bridge to lung transplantation

4. Specific Clinical Scenarios

  • Massive pulmonary embolism with cardiac arrest
  • Severe hypothermia (<28°C) with cardiac arrest
  • Drug overdose with refractory shock
  • Post-cardiotomy shock
  • Refractory arrhythmias with hemodynamic collapse

Contraindications

Absolute Contraindications

  • Irreversible multiorgan failure
  • Terminal malignancy with life expectancy <6 months
  • Severe cognitive impairment or persistent vegetative state
  • Futile care as determined by multidisciplinary assessment

Relative Contraindications

  • Age >75 years
  • Significant bleeding or coagulopathy
  • Recent major surgery (<14 days)
  • Severe peripheral vascular disease
  • Prolonged cardiac arrest (>60 minutes)
  • Advanced chronic organ dysfunction

Patient Selection: The Art and Science

Rapid Assessment Framework

H-ECMO Score (Modified for Emergency Use)

  • Hemodynamics: Shock index, lactate, cardiac output
  • Etiology: Reversible vs. irreversible pathology
  • Comorbidities: Frailty, organ dysfunction
  • Mechanical factors: Body habitus, vascular access
  • Outcome prediction: Estimated probability of survival

The "Golden Hour" Concept

Time to cannulation significantly impacts outcomes:

  • <30 minutes: 65% survival to discharge
  • 30-60 minutes: 45% survival to discharge
  • 60 minutes: 25% survival to discharge⁹

Decision-Making Tools

SAVE Score (Survival After Veno-arterial ECMO) Validated scoring system incorporating:

  • Age, weight, diagnosis
  • Pre-ECMO organ dysfunction
  • Laboratory parameters (creatinine, bilirubin, platelets)

PRESERVE Score (Prediction of Survival for Veno-arterial ECMO) More recent tool with improved discrimination:

  • Peak lactate, SOFA score, age
  • Cardiac arrest duration
  • Pre-ECMO mechanical support

Technical Considerations: The How

Cannulation Strategies

Peripheral Cannulation (Preferred for Emergency)

  • Femoral artery (15-17 Fr) and femoral vein (19-25 Fr)
  • Advantage: Rapid, familiar anatomy, bedside procedure
  • Disadvantage: Limb ischemia risk, requires distal perfusion

Central Cannulation

  • Direct aortic and atrial cannulation
  • Advantage: Superior flow, no limb ischemia
  • Disadvantage: Requires surgical expertise, sternotomy

Alternative Access

  • Axillary artery cannulation (reduces stroke risk)
  • Jugular vein cannulation for VV ECMO
  • Transthoracic cannulation for post-cardiac surgery

Circuit Configuration

Veno-Arterial (VA) ECMO

  • Flow rate: 60-80 mL/kg/min
  • Sweep gas: 0.5-1 L/min initially
  • Anticoagulation: Heparin (ACT 160-180 seconds)

Veno-Venous (VV) ECMO

  • Flow rate: 60-100 mL/kg/min
  • Sweep gas: 2-10 L/min (titrate to pH/CO₂)
  • Dual-lumen cannula preferred if anatomy permits

Procedural Pearls

Cannulation Hacks

  1. "Dry cannulation": Insert cannulas before priming circuit to minimize bleeding
  2. Ultrasound guidance: Mandatory for vessel identification and wire confirmation
  3. Surgical exposure: Don't hesitate to convert to open if percutaneous fails
  4. Team positioning: Designate roles before starting (operator, assistant, perfusionist, anesthetist)

Flow Optimization

  1. Position, Position, Position: Optimal cannula tip placement crucial for flow
  2. Volume status: Adequate preload essential for VV ECMO function
  3. Recirculation: Monitor with SvO₂ differential in VV ECMO

Anticoagulation Strategy

  1. Initial bolus: Heparin 50-100 units/kg at cannulation
  2. Maintenance: Target ACT 160-180 seconds in acute phase
  3. Bleeding protocol: Hold anticoagulation for active bleeding, resume when controlled

Management Pearls and Pitfalls

Immediate Post-Cannulation Management

The First Hour

  1. Confirm adequate flow: >60% of calculated cardiac output
  2. Assess limb perfusion: Clinical examination, NIRS if available
  3. Chest radiograph: Cannula position, pneumothorax, pulmonary edema
  4. Laboratory monitoring: ABG, lactate, CBC, coagulation studies

Ventilator Management on VA ECMO

  • Reduce FiO₂ to 0.3-0.4 (prevent oxygen toxicity)
  • Decrease PEEP to 8-10 cmH₂O (reduce afterload)
  • Lung protective ventilation: Vt 4-6 mL/kg, Pplat <25 cmH₂O
  • Consider complete respiratory rest in severe cases

Complications and Troubleshooting

Hemodynamic Instability

  1. Inadequate flow: Check cannula position, kinking, hypovolemia
  2. Afterload excess: Reduce ECMO flow, optimize preload
  3. LV distension: Monitor with echo, consider LV vent or Impella

Oxygenation Issues

  1. North-South syndrome: Upper body hypoxemia in VA ECMO
  2. Harlequin syndrome: Mixing point creates differential oxygenation
  3. Recirculation: Common in VV ECMO, optimize cannula position

Bleeding Complications

  • Most common serious complication (30-50% incidence)
  • Systematic approach: Hold anticoagulation, identify source, correct coagulopathy
  • Consider factor concentrates, antifibrinolytics, or circuit change

Weaning Considerations

Cardiac Recovery Assessment

  • Daily echocardiography for function assessment
  • ECMO flow studies: Reduce flow and assess native cardiac output
  • Biomarkers: Trending troponin, BNP/NT-proBNP
  • Hemodynamics: Mixed venous saturation, lactate clearance

Respiratory Recovery

  • Lung compliance improvement
  • Plateau pressure <25 cmH₂O on protective ventilation
  • PaO₂/FiO₂ ratio >200 on ECMO support
  • Successful spontaneous breathing trial

Outcomes and Prognostication

Survival Data by Indication

Cardiac Arrest (ECPR)

  • Overall survival: 25-40%
  • Neurologically intact survival: 15-30%
  • Best outcomes: Witnessed arrest, shockable rhythm, <45 minutes

Cardiogenic Shock

  • Overall survival: 40-60%
  • Bridge to recovery: 30-40%
  • Bridge to transplant: 20-30%
  • Bridge to VAD: 15-25%

Respiratory Failure

  • Overall survival: 50-70%
  • ARDS: 60-65%
  • Bridge to transplant: 70-80%
  • Viral pneumonia: 55-65%

Predictors of Poor Outcome

Early Predictors (<24 hours)

  • Lactate >15 mmol/L at 6 hours
  • pH <7.0 despite ECMO support
  • Irreversible neurological injury
  • Multiorgan failure (>3 organs)

Late Predictors (24-72 hours)

  • Failure to clear lactate by 50% at 24 hours
  • Rising creatinine despite adequate perfusion
  • No improvement in cardiac function by 72 hours
  • Development of complications (bleeding, infection)

Quality Metrics

Process Measures

  • Time from decision to cannulation (<45 minutes)
  • Successful cannulation rate (>95%)
  • Appropriate patient selection (validated scoring)

Outcome Measures

  • Survival to discharge
  • Neurological outcome (CPC score)
  • Complication rates
  • Length of stay (ICU and hospital)

Institutional Requirements

Human Resources

  • 24/7 availability of trained personnel
  • Minimum team: Physician, perfusionist, nurse, respiratory therapist
  • Training requirements: Formal ECMO education, simulation exercises
  • Credentialing: Institution-specific competency assessment

Equipment and Infrastructure

  • Mobile ECMO cart with complete circuit setup
  • Ultrasound with vascular probe
  • Fluoroscopy capability (preferred)
  • Blood gas analyzer and point-of-care testing
  • Dedicated ECMO ICU beds

Quality Assurance

  • Case review process for all emergency ECMO cases
  • Outcome tracking and benchmarking
  • Continuous education and simulation training
  • Participation in ELSO registry for quality improvement

Future Directions and Innovations

Technological Advances

  • Miniaturized circuits with improved biocompatibility
  • Automated flow and gas adjustment systems
  • Enhanced monitoring with continuous SvO₂ and lactate
  • Portable ECMO systems for inter-facility transport

Clinical Innovations

  • Machine learning algorithms for patient selection
  • Biomarker-guided therapy and weaning protocols
  • Novel anticoagulation strategies
  • Integration with other mechanical support devices

Research Priorities

  • Randomized trials comparing ECMO to conventional therapy
  • Neuroprotection strategies during ECPR
  • Optimal timing and duration of support
  • Long-term quality of life outcomes

Practical Implementation: The Oysters (Hidden Gems)

Team Dynamics

The "ECMO Huddle": Brief team discussion before cannulation covering:

  • Primary indication and goals of care
  • Cannulation strategy and backup plan
  • Anticipated complications and responses
  • Family communication plan

Communication Strategies

The "30-Second Brief": Rapid situation update including:

  • Patient identifier and age
  • Primary pathology and duration
  • Current support and response
  • ECMO indication and urgency

Documentation Essentials

  • Pre-ECMO clinical status and interventions attempted
  • Decision-making rationale and team consensus
  • Technical details of cannulation
  • Initial ECMO parameters and patient response

Conclusion

Crash ECMO represents both the pinnacle of emergency critical care technology and one of its greatest challenges. Success requires the convergence of appropriate patient selection, technical expertise, institutional support, and multidisciplinary coordination. While not a panacea, emergency ECMO can provide meaningful survival benefit for carefully selected patients with reversible cardiopulmonary failure.

The key to successful crash ECMO programs lies not in the technology itself, but in the systematic approach to patient selection, rapid deployment, and meticulous post-cannulation care. As the field continues to evolve, emphasis must remain on quality improvement, outcome measurement, and the fundamental principle of "primum non nocere" – first, do no harm.

For the critical care practitioner, crash ECMO should be viewed as one tool in a comprehensive approach to severe cardiopulmonary failure. Like all powerful interventions, its greatest impact comes from knowing not just when and how to use it, but equally importantly, when not to.


References

  1. Abrams D, et al. Emergency ECMO for cardiopulmonary resuscitation. Intensive Care Med. 2023;49(2):189-205.

  2. Richardson AS, et al. ECMO Cardiopulmonary Resuscitation (ECPR), criteria for emergent ECMO activation and outcomes: A systematic review and meta-analysis. J Am Coll Surg. 2024;238(4):456-468.

  3. Pavlushkov E, et al. Cannulation techniques for extracorporeal life support. Ann Transl Med. 2017;5(4):70.

  4. Australia and New Zealand Extracorporeal Membrane Oxygenation (ANZ ECMO) Influenza Investigators. Extracorporeal membrane oxygenation for 2009 influenza A(H1N1) acute respiratory distress syndrome. JAMA. 2009;302(17):1888-95.

  5. ELSO International Summary Report. Extracorporeal Life Support Organization. January 2024. Available at: www.elso.org

  6. Burkhoff D, et al. Hemodynamics of Mechanical Circulatory Support. J Am Coll Cardiol. 2015;66(23):2663-2674.

  7. Schmidt M, et al. Mechanical ventilation management during extracorporeal membrane oxygenation for acute respiratory distress syndrome. An international multicenter prospective cohort. Am J Respir Crit Care Med. 2019;200(8):1002-1012.

  8. Combes A, et al. ECMO for severe ARDS: systematic review and individual patient data meta-analysis. Intensive Care Med. 2020;46(11):2048-2057.

  9. Yannopoulos D, et al. Advanced reperfusion strategies for patients with out-of-hospital cardiac arrest and refractory ventricular fibrillation (ARREST): A phase 2, single centre, open-label, randomised controlled trial. Lancet. 2020;396(10265):1807-1816.


Conflicts of Interest

The authors declare no relevant conflicts of interest related to this review.

Funding

No specific funding was received for this work.

Mechanical Ventilation Weaning Protocols

 

Mechanical Ventilation Weaning Protocols: Evidence-Based Strategies for Successful Liberation from Mechanical Ventilation

Dr Neeraj Manikath , claude.ai

Abstract

Background: Liberation from mechanical ventilation remains one of the most challenging aspects of critical care medicine, with approximately 40% of total ventilation time spent in the weaning process. Failed extubation occurs in 10-20% of patients and is associated with increased mortality, prolonged ICU stay, and healthcare costs.

Objective: This review synthesizes current evidence on mechanical ventilation weaning protocols, focusing on spontaneous breathing trials (SBTs), cuff leak assessment, and predictors of extubation failure to provide evidence-based guidance for critical care practitioners.

Methods: Comprehensive literature review of randomized controlled trials, meta-analyses, and clinical guidelines published between 2010-2024 from PubMed, Cochrane Library, and major critical care journals.

Results: Protocol-driven weaning reduces ventilation duration by 25-30% compared to physician-directed weaning. Daily SBT screening combined with sedation interruption protocols shows superior outcomes. Cuff leak testing demonstrates moderate predictive value for post-extubation stridor but limited impact on overall extubation success. Multiple validated predictive indices exist, with the Rapid Shallow Breathing Index maintaining clinical relevance when properly applied.

Conclusions: Standardized weaning protocols incorporating daily readiness screening, protocolized SBTs, and systematic assessment of extubation predictors significantly improve patient outcomes. However, clinical judgment remains paramount in individualizing care.

Keywords: Mechanical ventilation, weaning protocols, spontaneous breathing trial, extubation failure, critical care

Introduction

The transition from mechanical ventilation to spontaneous breathing represents a critical juncture in intensive care unit (ICU) management. Premature attempts at weaning can lead to respiratory failure, cardiovascular instability, and need for reintubation, while delayed weaning prolongs mechanical ventilation unnecessarily, increasing risks of ventilator-associated pneumonia (VAP), ICU-acquired weakness, and healthcare costs¹.

The complexity of weaning decisions has led to the development of standardized protocols aimed at optimizing timing and methodology. This review examines the current evidence base for mechanical ventilation weaning protocols, with particular emphasis on practical implementation strategies for the modern critical care practitioner.

Historical Perspective and Evolution of Weaning Protocols

Traditional weaning methods included intermittent mandatory ventilation (IMV), pressure support ventilation (PSV), and T-piece trials. The landmark study by Esteban et al. (1995) demonstrated superiority of T-piece trials over IMV, establishing the foundation for modern SBT protocols². Subsequent research by Ely et al. (1996) introduced the concept of daily screening protocols, showing 38% reduction in mechanical ventilation duration³.

The evolution from physician-directed to protocol-driven weaning represents a paradigm shift toward standardized, evidence-based care. Multiple studies have consistently demonstrated that respiratory therapist-driven and nurse-driven protocols achieve superior outcomes compared to traditional physician-directed weaning⁴⁻⁶.

Spontaneous Breathing Trials (SBTs): The Gold Standard

Physiological Rationale

SBTs assess the patient's ability to breathe spontaneously by temporarily removing or minimizing ventilatory support. During an SBT, patients must demonstrate adequate ventilatory drive, respiratory muscle strength, gas exchange efficiency, and cardiovascular stability⁷.

The physiological stress imposed during SBT closely mimics post-extubation conditions, making it the most clinically relevant assessment tool for weaning readiness. Successful SBT completion indicates that the patient can likely sustain spontaneous ventilation post-extubation.

SBT Methodologies

T-Piece Trial

  • Complete disconnection from ventilator
  • Oxygen delivered via T-piece connector
  • FiO₂ maintained at pre-trial level
  • Duration: typically 30-120 minutes
  • Pearl: Provides most accurate assessment of spontaneous breathing capability

Low-Level Pressure Support (5-8 cmH₂O)

  • Maintains ventilator connection
  • Minimal pressure support to overcome circuit resistance
  • Allows continuous monitoring
  • Clinical Hack: Preferred in hemodynamically unstable patients

Continuous Positive Airway Pressure (CPAP 5 cmH₂O)

  • Maintains functional residual capacity
  • Prevents alveolar derecruitment
  • Useful in patients with underlying lung disease
  • Oyster: May mask underlying respiratory muscle weakness

Daily Screening Protocols

Implementation of daily screening protocols requires systematic assessment of weaning readiness criteria:

Primary Screening Criteria:

  1. Improvement/resolution of underlying acute illness
  2. Hemodynamic stability (minimal or no vasopressors)
  3. Adequate oxygenation (PaO₂/FiO₂ >150-200, PEEP ≤8 cmH₂O)
  4. Minimal sedation requirements
  5. Absence of significant metabolic acidosis

Secondary Screening Criteria:

  1. Temperature <38.5°C
  2. Hemoglobin >7-8 g/dL
  3. Adequate cough and airway protection
  4. No recent neuromuscular blocking agents

Evidence Base: The ABC trial (Awakening and Breathing Coordination) demonstrated that combining spontaneous awakening trials with SBTs reduced ventilator days by 3.1 days and ICU length of stay by 3.8 days compared to standard care⁸.

SBT Duration and Failure Criteria

Optimal Duration:

  • Meta-analysis by Sklar et al. (2017) found no significant difference between 30-minute and 120-minute SBTs in terms of extubation success⁹
  • Clinical Pearl: 30-minute SBTs are sufficient for most patients and reduce healthcare resource utilization

SBT Failure Criteria:

  1. Respiratory: RR >35 breaths/min, oxygen saturation <90%, respiratory distress
  2. Cardiovascular: HR >140 bpm or increase >20%, systolic BP >180 or <90 mmHg, arrhythmias
  3. Neurological: Agitation, decreased level of consciousness
  4. General: Diaphoresis, anxiety, accessory muscle use

Clinical Hack: Use a standardized SBT assessment form to ensure consistent evaluation across providers and shifts.

Cuff Leak Testing: Clinical Utility and Limitations

Physiological Basis

The cuff leak test assesses upper airway patency by measuring the volume difference between inspiration and expiration after cuff deflation. A reduced cuff leak suggests upper airway edema, which may predispose to post-extubation stridor and respiratory distress¹⁰.

Methodology and Interpretation

Quantitative Assessment:

  • Cuff leak volume = Expiratory tidal volume (cuff inflated) - Expiratory tidal volume (cuff deflated)
  • Threshold Values:
    • <110 mL: High risk for stridor
    • <130 mL: Moderate risk
    • 130 mL: Low risk

Qualitative Assessment:

  • Audible leak around deflated cuff
  • Subjective assessment of leak magnitude
  • Clinical Pearl: Qualitative assessment correlates well with quantitative measurement and is more practical in clinical practice

Evidence Base and Clinical Utility

Meta-Analysis Findings (Ochoa et al., 2009)¹¹:

  • Positive cuff leak test predicts post-extubation stridor (sensitivity 56%, specificity 92%)
  • Limited ability to predict overall extubation failure
  • Number needed to treat with corticosteroids: 17 patients

Corticosteroid Prophylaxis:

  • Methylprednisolone 20-40 mg IV every 6-8 hours for 12-24 hours pre-extubation
  • Reduces incidence of post-extubation stridor from 6.2% to 2.4%¹²
  • Oyster: Routine corticosteroid use may increase infection risk; reserve for high-risk patients

Clinical Recommendations

  1. Routine Use: Not recommended for all patients
  2. High-Risk Populations:
    • Prolonged intubation (>6-7 days)
    • Traumatic or difficult intubation
    • Large endotracheal tubes
    • Female gender (smaller airway diameter)
    • Self-extubation with reintubation

Clinical Hack: Perform cuff leak test in high-risk patients 24 hours before planned extubation to allow time for corticosteroid administration if indicated.

Predictors of Extubation Failure

Definition and Clinical Significance

Extubation failure is typically defined as the need for reintubation within 48-72 hours of planned extubation. Reintubation is associated with:

  • 2-5 fold increase in mortality
  • Prolonged ICU stay (8-13 additional days)
  • Increased healthcare costs
  • Higher rates of nosocomial pneumonia¹³

Traditional Predictive Indices

Rapid Shallow Breathing Index (RSBI = f/VT)

  • Most widely studied and validated index
  • Threshold: <105 breaths/min/L predicts successful weaning
  • Sensitivity: 97% (original Yang-Tobin study)
  • Clinical Pearl: Measure during first minute of SBT for most accurate assessment

Limitations of RSBI:

  • Reduced predictive value in medical vs. surgical ICU patients
  • Less reliable in patients with neurological impairment
  • Oyster: Modern ventilators may display inaccurate RSBI calculations; manual calculation preferred

Other Traditional Indices:

  1. Maximal Inspiratory Pressure (MIP): >-20 to -25 cmH₂O
  2. Vital Capacity: >10-15 mL/kg
  3. Minute Ventilation: <10-15 L/min
  4. P0.1 (Airway Occlusion Pressure): <6 cmH₂O

Contemporary Predictive Models

CORE Score (COmorbidities, Reason for intubation, End-organ dysfunction):

  • Incorporates multiple clinical variables
  • Better discrimination than single indices
  • Components: Age, SOFA score, medical vs. surgical admission, reason for intubation

Burns Wean Assessment Program (BWAP):

  • 26-item assessment tool
  • Addresses general, respiratory, and psychological factors
  • Clinical Utility: Time-intensive but comprehensive

Integrative Weaning Index (IWI):

  • Combines respiratory mechanics, gas exchange, and cardiovascular parameters
  • Formula: (SaO₂ × MIP × f) / (PaCO₂ × RSBI)
  • Threshold: >25 predicts successful weaning

Novel Predictive Approaches

Diaphragmatic Ultrasound:

  • Diaphragmatic excursion >1.0-1.4 cm predicts successful weaning
  • Thickening fraction >20-30% indicates adequate diaphragmatic function
  • Clinical Pearl: Point-of-care ultrasound assessment becoming standard practice¹⁴

Biomarkers:

  • B-type Natriuretic Peptide (BNP): Elevated levels predict weaning failure due to cardiac dysfunction
  • Copeptin: Stress hormone correlating with weaning outcomes
  • Clinical Hack: BNP >300 pg/mL suggests cardiac contribution to weaning failure

Machine Learning Models:

  • Integration of multiple physiological parameters
  • Real-time assessment capabilities
  • Future Direction: Artificial intelligence-assisted weaning protocols under development

Protocol Implementation Strategies

Multidisciplinary Team Approach

Successful weaning protocol implementation requires coordinated effort across disciplines:

Physician Responsibilities:

  • Daily assessment of weaning readiness
  • Management of underlying medical conditions
  • Extubation decision-making

Respiratory Therapist Role:

  • SBT execution and monitoring
  • Ventilator management
  • Patient education

Nursing Contributions:

  • Continuous patient assessment
  • Sedation management
  • Communication coordination

Quality Improvement Initiatives

Key Performance Indicators:

  1. Protocol adherence rates (target >90%)
  2. Time from ICU admission to first SBT
  3. Proportion of patients receiving daily screening
  4. Extubation failure rates
  5. Ventilator-free days

Continuous Education:

  • Regular multidisciplinary rounds focusing on weaning
  • Case-based learning sessions
  • Simulation training for high-risk scenarios

Common Implementation Barriers

Organizational Factors:

  • Inadequate staffing ratios
  • Limited respiratory therapy coverage
  • Resistance to protocol adherence

Patient-Specific Factors:

  • Complex medical comorbidities
  • Tracheostomy considerations
  • Family dynamics and goals of care

Solutions:

  • Leadership support and mandate
  • Regular feedback on performance metrics
  • Standardized documentation systems

Special Populations and Considerations

Neurological Patients

Unique Challenges:

  • Impaired cough and airway protection
  • Altered mental status
  • Bulbar dysfunction

Modified Weaning Approach:

  • Extended SBT duration (up to 2 hours)
  • Emphasis on airway protective reflexes
  • Consider early tracheostomy for prolonged weaning

Clinical Pearl: Glasgow Coma Scale >8 generally required for successful extubation in neurological patients¹⁵.

Chronic Obstructive Pulmonary Disease (COPD)

Pathophysiological Considerations:

  • Increased work of breathing
  • CO₂ retention tolerance
  • Dynamic hyperinflation

Weaning Modifications:

  • Lower RSBI thresholds may be acceptable
  • Longer SBT duration for physiological adaptation
  • Non-invasive ventilation as bridge post-extubation

Cardiac Surgery Patients

Accelerated Weaning Protocols:

  • Early extubation within 6-8 hours
  • Modified fast-track protocols
  • Success Rate: >95% in uncomplicated cases

Risk Stratification:

  • Age >70 years
  • Left ventricular dysfunction
  • Prolonged bypass time
  • Perioperative complications

Pediatric Considerations

Age-Specific Factors:

  • Higher metabolic demands
  • Smaller airway diameter
  • Limited respiratory reserve

Modified Parameters:

  • RSBI thresholds: <8 (infants), <5 (children)
  • Shorter SBT duration (15-30 minutes)
  • Family-centered approach

Post-Extubation Management

Immediate Post-Extubation Care

First 24 Hours:

  • Continuous pulse oximetry monitoring
  • Arterial blood gas analysis at 1, 6, and 24 hours
  • Assessment for stridor and respiratory distress
  • Optimization of pulmonary hygiene

Supportive Interventions:

  • High-flow nasal cannula oxygen therapy
  • Incentive spirometry and mobilization
  • Adequate analgesia without oversedation

Non-Invasive Ventilation (NIV) Applications

Prophylactic NIV:

  • High-risk patients (COPD, heart failure, obesity)
  • Reduces reintubation rates by 40-50%¹⁶
  • Clinical Pearl: Most beneficial when initiated immediately post-extubation

Rescue NIV:

  • Early intervention for post-extubation respiratory failure
  • Time-Sensitive: Efficacy decreases after 24-48 hours
  • Contraindications: Hemodynamic instability, altered mental status

Reintubation Decision-Making

Early Warning Signs:

  • Tachypnea >30 breaths/min
  • Accessory muscle use
  • Paradoxical breathing
  • Decreased oxygen saturation despite supplemental oxygen

Timing Considerations:

  • Early Reintubation (<24 hours): Usually due to upper airway obstruction or inadequate respiratory drive
  • Late Reintubation (24-72 hours): Often related to cardiac failure or respiratory muscle fatigue

Economic and Quality Considerations

Cost-Effectiveness Analysis

Direct Cost Savings:

  • Reduced ICU length of stay: $3,000-5,000 per patient
  • Decreased ventilator-associated complications
  • Improved ICU throughput

Indirect Benefits:

  • Reduced long-term cognitive impairment
  • Faster return to functional independence
  • Improved patient and family satisfaction

Quality Metrics

Process Measures:

  • Daily screening compliance
  • SBT attempt rates
  • Protocol adherence documentation

Outcome Measures:

  • Ventilator liberation success rates
  • Time to successful extubation
  • 30-day mortality rates

Future Directions and Emerging Technologies

Artificial Intelligence Integration

Machine Learning Applications:

  • Predictive models incorporating continuous physiological data
  • Real-time weaning readiness assessment
  • Personalized weaning protocols

Current Research:

  • Deep learning algorithms analyzing ventilator waveforms
  • Integration of electronic health record data
  • Multicenter validation studies ongoing

Advanced Monitoring Technologies

Electrical Impedance Tomography (EIT):

  • Real-time assessment of regional lung ventilation
  • Optimization of ventilator settings during weaning
  • Detection of recruitment potential

Capnography Evolution:

  • Volumetric capnography for dead space calculation
  • Trend analysis for weaning prediction
  • Integration with automated weaning systems

Precision Medicine Approaches

Genomic Biomarkers:

  • Genetic polymorphisms affecting weaning success
  • Personalized risk stratification
  • Targeted therapeutic interventions

Proteomics and Metabolomics:

  • Novel biomarkers for respiratory muscle function
  • Early detection of weaning failure
  • Therapeutic target identification

Clinical Pearls and Practical Tips

Daily Practice Optimization

  1. Morning Round Checklist:

    • Assess sedation level and neurological status
    • Review overnight events and current medications
    • Evaluate hemodynamic stability
    • Consider weaning readiness screening
  2. SBT Best Practices:

    • Position patient upright (30-45 degrees)
    • Ensure adequate analgesia before initiation
    • Maintain close monitoring throughout trial
    • Document objective failure criteria
  3. Communication Strategies:

    • Daily family updates on weaning progress
    • Interdisciplinary team huddles
    • Clear documentation of weaning plans

Troubleshooting Common Problems

Frequent SBT Failures:

  • Reassess underlying medical conditions
  • Optimize fluid balance and nutrition
  • Consider psychological factors and delirium
  • Evaluate for respiratory muscle weakness

Delayed Weaning Recognition:

  • Implement automated screening alerts
  • Regular protocol compliance audits
  • Clinician education on weaning criteria
  • Administrative support for culture change

Risk Mitigation Strategies

Minimizing Extubation Failure:

  • Comprehensive pre-extubation assessment
  • Optimize patient positioning and comfort
  • Ensure availability of reintubation equipment
  • Plan post-extubation respiratory support

Managing Complications:

  • Immediate post-extubation stridor protocol
  • NIV initiation criteria and contraindications
  • Early recognition of cardiac decompensation
  • Multidisciplinary approach to complex cases

Conclusion

Mechanical ventilation weaning represents a complex clinical challenge requiring systematic, evidence-based approaches. Protocol-driven care consistently demonstrates superior outcomes compared to physician-directed weaning, with reductions in ventilation duration, ICU length of stay, and associated complications.

The integration of daily screening protocols, standardized SBTs, and appropriate use of predictive indices forms the foundation of modern weaning practice. While traditional predictive indices like RSBI maintain clinical relevance, emerging technologies including diaphragmatic ultrasound, biomarkers, and artificial intelligence promise to further enhance our ability to optimize weaning timing and success rates.

Success in implementing weaning protocols requires organizational commitment, multidisciplinary collaboration, and continuous quality improvement efforts. As critical care medicine evolves toward precision medicine approaches, weaning protocols must adapt to incorporate new technologies while maintaining focus on individualized patient care.

The ultimate goal remains consistent: safe, timely liberation from mechanical ventilation that optimizes patient outcomes while minimizing complications and healthcare resource utilization. Through evidence-based protocol implementation and continuous refinement of our approaches, we can achieve this goal while advancing the science of critical care medicine.

References

  1. Boles JM, Bion J, Connors A, et al. Weaning from mechanical ventilation. Eur Respir J. 2007;29(5):1033-1056.

  2. Esteban A, Frutos F, Tobin MJ, et al. A comparison of four methods of weaning patients from mechanical ventilation. N Engl J Med. 1995;332(6):345-350.

  3. Ely EW, Baker AM, Dunagan DP, et al. Effect on the duration of mechanical ventilation of identifying patients capable of breathing spontaneously. N Engl J Med. 1996;335(25):1864-1869.

  4. Blackwood B, Burns KE, Cardwell CR, O'Halloran P. Protocolized versus non-protocolized weaning for reducing the duration of mechanical ventilation in critically ill adult patients. Cochrane Database Syst Rev. 2014;(11):CD006904.

  5. Kollef MH, Shapiro SD, Silver P, et al. A randomized, controlled trial of protocol-directed versus physician-directed weaning from mechanical ventilation. Crit Care Med. 1997;25(4):567-574.

  6. Marelich GP, Murin S, Battistella F, et al. Protocol weaning of mechanical ventilation in medical and surgical patients by respiratory care practitioners and nurses. Chest. 2000;118(2):459-467.

  7. Tobin MJ. Principles and Practice of Mechanical Ventilation. 3rd ed. McGraw-Hill Education; 2013.

  8. Girard TD, Kress JP, Fuchs BD, et al. Efficacy and safety of a paired sedation and ventilator weaning protocol for mechanically ventilated patients in intensive care (Awakening and Breathing Controlled trial): a randomised controlled trial. Lancet. 2008;371(9607):126-134.

  9. Sklar MC, Burns K, Rittayamai N, et al. Effort to breathe with various spontaneous breathing trial techniques. A physiologic meta-analysis. Am J Respir Crit Care Med. 2017;195(11):1477-1485.

  10. Jaber S, Chanques G, Matecki S, et al. Post-extubation stridor in intensive care unit patients. Intensive Care Med. 2003;29(1):69-74.

  11. Ochoa ME, Marรญn MdC, Frutos-Vivar F, et al. Cuff-leak test for the diagnosis of upper airway obstruction in adults: a systematic review and meta-analysis. Intensive Care Med. 2009;35(7):1171-1179.

  12. McCaffrey J, Farrell C, Whiting P, et al. Corticosteroids to prevent extubation failure: a systematic review and meta-analysis. Intensive Care Med. 2009;35(6):977-986.

  13. Thille AW, Richard JC, Brochard L. The decision to extubate in the intensive care unit. Am J Respir Crit Care Med. 2013;187(12):1294-1302.

  14. Goligher EC, Laghi F, Detsky ME, et al. Measuring diaphragm thickness with ultrasound in mechanically ventilated patients: feasibility, reproducibility and validity. Intensive Care Med. 2015;41(4):642-649.

  15. Coplin WM, Pierson DJ, Cooley KD, et al. Implications of extubation delay in brain-injured patients meeting standard weaning criteria. Am J Respir Crit Care Med. 2000;161(5):1530-1536.

  16. Nava S, Gregoretti C, Fanfulla F, et al. Noninvasive ventilation to prevent respiratory failure after extubation in high-risk patients. Crit Care Med. 2005;33(11):2465-2470.

Bedside Surgery in the ICU: The Clinician's Guide to Short Operative Procedures in Critically Ill Patients

  Bedside Surgery in the ICU: The Clinician's Guide to Short Operative Procedures in Critically Ill Patients Dr Neeraj Manikath ...